VMP 34955111000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler
BNF code 0302000Z0AAAAAA
Virtual Therapeutic Moiety Fluticasone + Umeclidinium bromide + Vilanterol
Basis of preferred name Other
Prescribing status Never Valid To Prescribe As A VMP
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units dose
Unit dose unit of measure dose
Virtual Product Ingredient
Ingredient Vilanterol trifenatate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 702408004
Strength value numerator 22.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Virtual Product Ingredient
Ingredient Umeclidinium bromide
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 706898002
Strength value numerator 55.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Virtual Product Ingredient
Ingredient Fluticasone furoate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 92.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Ontology Drug Form & Route
Form & Route powderinhalation.inhalation
Dose Form
Formulation Inhalation powder
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)
Virtual Medicinal Product Packs
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler 30 dose

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback